|
Class 2 Device Recall TSXIOI: AQUILION 32/64; System |
|
Date Initiated by Firm |
November 30, 2011 |
Date Posted |
April 08, 2013 |
Recall Status1 |
Terminated 3 on June 17, 2013 |
Recall Number |
Z-1067-2013 |
Recall Event ID |
64667 |
Product Classification |
System, x-ray, tomography, computed - Product Code JAK
|
Product |
TSX-IOI: AQUILION 32/64; System, X-Ray, Tomography, Computed.
Designed to produce cross-sectional images of a human body. |
Code Information |
Serial Numbers: HDA0722595 JDA0972130 JDA0972135 JDA0992147 JDA09Y2158 KDA09X2063 JDA09Y2157 JDA09Y2161 JDA1012171 JDA10X2191 JDA10X2197 JDA10Z2214 JGAl112220 JLA1122232 JLA1132235 JDAl112216 JDAl112219 NLA0972032 JDA1182242 JDA1182241 JDA1182244 JDA1072183 JDA1082189 |
Recalling Firm/ Manufacturer |
Toshiba American Medical Systems Inc 2441 Michelle Dr P.O. Box 2068 Tustin CA 92780-7047
|
For Additional Information Contact |
714-730-5000
|
Manufacturer Reason for Recall |
The firm initiated this recall due to a potential software issue. The DLP (Dose Length Product) value may be displayed incorrectly when the vHP option is used.
|
FDA Determined Cause 2 |
Process design |
Action |
Toshiba sent "URGENT: MEDICAL DEVICE CORRECTION" letters to all affected customers. The letter identified the product, problem, and actions to be taken by the customers. The letter contained a return reply form that is to be faxed to TAMS for retention. Contact the firm at (800) 421-1968 for questions relating to this letter. |
Quantity in Commerce |
23 units |
Distribution |
Nationwide Distribution including the states of WA, OH, CA, TX, WV, IL, AZ, CA, WI, ME, WI, NC, FL, MT, and HI. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|